Viropro, Inc. (VPRO)

[FlyingScot]

Conference was pretty good, no mention of VPRO as I thought, but a way stronger message than their last presentation. They have huge revenues expected this year, and two NDA approvals in the pipeline. While they did not talk VPRO directly they mentioned the Biosimilar process and the fact that they now have zero debt and 111Million in liquid assets to pursue other drug lines.

some good Q&A at the end about their contigencies if some of their developmentals don't go all the way through. Also he mentioned that although the FDA haven't fully cleared their colorectal cancer drug, they are allowing it to be used through direct request although they can't market it.

all positive stuff